Authorized persons for stock exchange disclosures updated

Compliance View source PDF Explain this filing

AARTIDRUGS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.1%Reaction day

₹419.00

prior close

₹424.90

announcement price

After-mkt

timing

Nifty Microcap 250market+0.0%-1.1% vs market

Pharmaceuticals peers, median of 173sector-0.7%-0.4% vs sector

On the reaction day the stock moved 1.1 pts less than Nifty Microcap 250 and 0.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.2

10m

-0.4

15m

-0.3

30m

-0.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.1+0.0-1.1-0.7-0.4

Next day

+2.3+1.3+0.9+0.6+1.7

-0.3+1.1-1.4+0.4-0.7

-0.2-1.7+1.5-2.3+2.1

-1.6-1.4-0.1-2.1+0.6

-1.7-0.6-1.1-2.5+0.8

-4.5+0.3-4.8-2.4-2.0

15d

-3.7pendingpending-4.4+0.7

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Aarti Drugs has informed the stock exchanges about updated authorized persons under SEBI LODR Regulation 30(5), effective October 1, 2026. Managing Director Adhish P. Patil and Joint Managing Director Harshit M. Savla will determine materiality of events, along with Company Secretary Rushikesh V. Deole who will make disclosures to stock exchanges. This follows recent changes in the company directorate.

Likely market impact

Routine compliance update; no change in business or financial outlook for shareholders.